Material matters: exploring the interplay between natural biomaterials and host immune system

Abstract

Biomaterials are widely used for various medical purposes, for instance, implants, tissue engineering, medical devices, and drug delivery systems. Natural biomaterials can be obtained from proteins, carbohydrates, and cell-specific sources. However, when these biomaterials are introduced into the body, they trigger an immune response which may lead to rejection and failure of the implanted device or tissue. The immune system recognizes natural biomaterials as foreign substances and triggers the activation of several immune cells, for instance, macrophages, dendritic cells, and T cells. These cells release pro-inflammatory cytokines and chemokines, which recruit other immune cells to the implantation site. The activation of the immune system can lead to an inflammatory response, which can be beneficial or detrimental, depending on the type of natural biomaterial and the extent of the immune response. These biomaterials can also influence the immune response by modulating the behavior of immune cells. For example, biomaterials with specific surface properties, such as charge and hydrophobicity, can affect the activation and differentiation of immune cells. Additionally, biomaterials can be engineered to release immunomodulatory factors, such as anti-inflammatory cytokines, to promote a tolerogenic immune response. In conclusion, the interaction between biomaterials and the body’s immune system is an intricate procedure with potential consequences for the effectiveness of therapeutics and medical devices. A better understanding of this interplay can help to design biomaterials that promote favorable immune responses and minimize adverse reactions.

Biomaterials targeting the microenvironment for spinal cord injury repair: progression and perspectives

“…Alginate also enhances toll-like receptor 4 (TLR4)-NF-κB-mediated phagocytosis in macrophages. Alginate enhanced phagocytosis in mouse macrophages by increasing TLR4 expression, activating the protein kinase B (AKT)/NF-κB and p8MAPK signaling pathways, and inducing macrophage activation ( Tripathi et al, 2023 ).…”

Challenges and Pitfalls of Research Designs Involving Magnesium-Based Biomaterials: An Overview

“…Since the application of biomaterials into the human body, there have been ongoing concerns about their safety and effectiveness, prompting the exploration of clinical and preclinical evaluation methods [ 28 ]. The term ‘biocompatibility’ is defined as the ‘ability of a material to perform with an appropriate host response in a specific application’ [ 29 , 30 ].…”

“…Chemical interactions between biomaterials and the host occur not only at the material surfaces, but also involve chemical molecules that the materials may release into the body [ 140 ]. All types of materials used in constructing biomedical devices have the potential to release degradation products, but resorbable materials are designed to do so in a controlled manner [ 28 , 68 ]. Polymeric biomaterials can release particles, oligomers, monomers, and additives, while metallic implants may release metal ions, metal particles, and polycations.…”

“…Recent studies have highlighted the influence of immunological signals on the interaction between biomaterials and the host, and the potential role of genetically or acquired immunological disorders in biomaterial rejection [ 28 , 204 ]. Similarly, rheumatoid arthritis (RA), an autoimmune condition, has been demonstrated to have a significant impact on bone loss around implants and implant failure, both in the jaw and in joint replacement procedures.…”

“…( B ) The stages of wound healing in the presence of implanted biomaterial involve a dynamic interaction between the extracellular matrix and different cell types, including endothelial cells, platelets, fibroblasts, keratinocytes, and macrophages [ 67 ]. ( C ) Release of particles and ions from the implanted biomaterial and the subsequent degradation process [ 28 , 68 ].…”